好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Characterizing Neurodevelopmental Function in ZARD: Insights from the Vineland Adaptive Behavior Scale
Child Neurology and Developmental Neurology
P8 - Poster Session 8 (11:45 AM-12:45 PM)
8-009

To characterize differences in neurodevelopmental outcomes by sex and mutation type among pediatric patients with ZC4H2-Associated Rare Disorders (ZARD).

ZARD comprises a spectrum of X-linked syndromes caused by pathogenic variants in the ZC4H2 gene, which encodes a zinc-finger protein essential for spinal cord development. Animal studies show ZC4H2 mutations impair synaptic plasticity and long-term potentiation, mechanisms vital for learning and memory. Prior studies highlight sex differences and genotype–phenotype correlations in individuals with ZARD; however, characterization of neurodevelopmental profiles remains limited. Adaptive behavior—encompassing conceptual, social, and practical skills needed for independent functioning—offers a useful framework for assessing neurodevelopmental differences. This study examines sex- and mutation-associated differences in adaptive behavior among individuals with ZARD.

The ZARD Natural History Study is a prospective, longitudinal study following participants with confirmed ZC4H2 pathogenic variants at six-month intervals. This analysis focuses on data from the Vineland Adaptive Behavior Scales, Third Edition (Vineland-3), which measures communication, daily living, and socialization domains, with an optional motor skills domain. ANOVA and two-sample t-tests with unequal variances were used for analysis.

Forty participants completed baseline Vineland-3 assessments, and twenty-five completed a one-year follow-up evaluation. Females demonstrated significantly higher mean standard scores and large effect sizes in the Adaptive Behavior Composite (p=0.03, Cohen's d=0.78), particularly in communication (p=0.02, Cohen's d=0.76) and socialization (p=0.03, Cohen's d=0.76) domains. There were no significant differences between mutation types. Across all domains, mean change from baseline to one-year follow-up showed a negative trend, though differences were not significant by sex or mutation type.

Overall, participants demonstrated decline in adaptive behavior over time. Findings suggest sex-related differences in adaptive functioning among individuals with ZARD, with females more likely to show higher adaptive function, potentially informing prognosis and individualized intervention. Ongoing longitudinal follow-up will further clarify developmental trajectories and genotype–phenotype relationships in this rare neurodevelopmental disorder.

Authors/Disclosures
Sue Park
PRESENTER
Miss Park has nothing to disclose.
Kristin Falbo, MS Mrs. Falbo has nothing to disclose.
William T. Raskopf Mr. Raskopf has nothing to disclose.
Sara Morcos Ms. Morcos has nothing to disclose.
David Bearden, MD (University of Rochester School of Medicine) Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.